Aug 2017

Sale of a Utility-Ready Biologics / Vaccines Manufacturing Site

Shire Krems

PharmaBioSource provided transaction consulting services to Shire on the divestment of its 340,000 SF Krems, Austria vaccines manufacturing site to Merck Animal Health.

  • Service: Transaction Consulting
  • Sector: Biotechnology / Animal Health
  • Sub-sector: Vaccines
  • Engagement Type: Sell Side

PharmaBioSource provided comprehensive transaction services to divest Shire’s biologics / vaccines manufacturing site near Vienna, Austria.  The site was acquired by Merck Animal Health to expand its global vaccine manufacturing capacity.

PharmaBioSource’s services included a benchmark valuation, buyer target identification, creation of the confidential information memorandum (CIM), data room development and due diligence support.

Press Release

Transactions

View All Transactions
Sep 2024

Reckitt Acquires The Sandoz Oral Solid Dosage Manufacturing Facility In Wilson, North Carolina

Read More
Dec 2023

PharmaBioSource Advises Lubrizol on the Sale of Particle Sciences to Agno Pharma

Read More
Nov 2023

Indivior Acquires Sagent Pharmaceutical's Sterile Injectable Fill / Finish Manufacturing Facility in Raleigh, North Carolina

Read More
Jan 2022

Sale of Sterile Fill / Finish & Topical Liquids & Creams Manufacturing & Packaging Facility in New Jersey for $27M

Read More
Jul 2020

Sale of an Oral Solids and Liquids Manufacturing Operation in the U.S.

Read More
Aug 2019

Sale of Soft Gel Development and Manufacturing Assets and Facility Lease

Read More
Jun 2019

Lease of Small Molecule API Research and Development Facility with Kilo Labs and Pilot Plant

Read More
Jun 2019

Divestment of a Small Molecule API Manufacturing Site in Lodi, Italy

Read More
Jun 2019

Divestment of a Sterile Fill / Finish Manufacturing Facility & CMO Business in León, Spain

Read More